Company news

Precipio, Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Precipio Announces 95% Annual Growth YoY and 180% Quarterly Growth YoY

March 29, 2021

Precipio Announces Q4-2020 and year-end Shareholder Update Call

March 17, 2021

Mr. Ron Andrews joins Precipio’s Board of Directors

March 2, 2021

Mr. Richard Sandberg is appointed Chairman of Precipio’s Board of Directors

March 2, 2021

Precipio Launches COVID-19 Antibody Testing at Point-of-Care

January 27, 2021

Precipio Signs HemeScreen™ Deals with Two Leading Oncology Groups

January 19, 2021

Precipio Signs Sales & Marketing Agreement for HemeScreen™ with Major Oncology Distributor

December 9, 2020

Precipio Launches its Proprietary HemeScreen™ AML (Acute Myeloid Leukemia) Molecular Panel

September 21, 2020

Precipio & ADS Biotec Sign Global Distribution Agreement for IV-Cell™

August 19, 2020

Precipio Launches Covid-19 Antibody Test in its CLIA laboratory

August 3, 2020

Precipio Announces Commercial Launch of COVID-19 Antibody Test

July 29, 2020

Precipio Announces Q2-2020 Unaudited Pathology Services Revenue Increased Approximately 50% over Q1’20

July 21, 2020

Precipio Regains Listing Compliance with NASDAQ Minimum Bid Requirement

June 30, 2020

Precipio Launches New HemeScreen™ Reagent Rental Program

April 5, 2020

Precipio Announces the Resignation of Samuel Riccitelli and the Introduction of Richard Sandberg to its Board of Directors

December 3, 2019

Precipio Announces Shareholder Update Call on Commercial Progress

October 1, 2019

Mr. Ori Karev Joins Precipio Executive Team As Chief Strategy Officer

April 17, 2019

← Newer news releases

Calls

The 5 newest of 9 calls. Every call is listed under its year.

Decks